Susquehanna International Group, LLP Adamas Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	N/A	-38,545 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	N/A	24,619 Added 176.78%	38,545 $189,000
Q4 2020 Feb 16, 2021	SELL	N/A	-3,350 Reduced 19.39%	13,926 $60,000
Q1 2020 May 15, 2020	SELL	N/A	-45,947 Reduced 72.67%	17,276 $50,000
Q4 2019 Feb 14, 2020	BUY	N/A	2,405 Added 3.95%	63,223 $240,000
Q3 2019 Nov 14, 2019	SELL	N/A	-38,177 Reduced 38.56%	60,818 $311,000
Q2 2019 Aug 16, 2019	BUY	N/A	1,033 Added 1.05%	98,995 $614,000
Q2 2019 Aug 14, 2019	BUY	N/A	33,610 Added 52.23%	97,962 $607,000
Q1 2019 May 15, 2019	BUY	N/A	16,693 Added 35.03%	64,352 $458,000
Q4 2018 Feb 14, 2019	BUY	N/A	35,783 Added 301.31%	47,659 $407,000
Q2 2018 Aug 14, 2018	SELL	N/A	-122,589 Reduced 91.17%	11,876 $307,000
Q4 2017 Feb 14, 2018	SELL	N/A	-76,395 Reduced 36.23%	134,465 $4.56 Million
Q3 2017 Nov 14, 2017	BUY	N/A	210,860	210,860 $4.46 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.